EUCTR2019-003992-21-DE进行中（未招募）1 期
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study of the Efficacy and the Safety and Tolerability of BMS-986278 in Participants with Pulmonary Fibrosis - Phase 2 Study of the Efficacy and Safety of BMS-986278 in Pulmonary Fibrosis
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 360
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •For the idiopathic pulmonary fibrosis (IPF) Cohort:
- •- Diagnosis of IPF within 7 years
- •- Female and males = 40 years of age
- •For the progressive fibrotic interstitial lung disease (PF-ILD) Cohort:
- •-Evidence of progressive ILD within the 24 months before screening
- •-Female and male = 21 years of age.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 90
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 270
排除标准
- •_Women who are of childbearing potential
- •_Active Smokers
- •_Patients with current malignancy
- •_ History of allergy to BMS-986278 or related compounds
研究者
相似试验
进行中（未招募）
不适用
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously in Subjects with Active Rheumatoid Arthritis and Previously Treated with Biologic Anti-TNFalfa Agent(s) - NAActive rheumatoid arthritis (RA)EUCTR2005-001742-16-NLCentocor B.V.420
招募中
不适用
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to evaluate the efficacy and safety of ginkgo biloba leaf ex. inj. in Salvage treatment for Sudden Deafness PatientsDiseases of the ear and mastoid processKCT0003292Asan Medical Center68
进行中（未招募）
不适用
A clinical trial to test the safety and effectiveness of aripiprazole against placebo in children and adolescents with Tourette’s DisorderEUCTR2012-003488-23-HUOtsuka Pharmaceutical Development & Commercialization, Inc.67
进行中（未招募）
1 期
A Study to Investigate safety and how well ABBV-323 works and how safe it is in Subjects with Moderate to Severe Ulcerative Colitis Who Failed Prior Therapylcerative ColitisMedDRA version: 20.1Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 100000004856EUCTR2018-000930-37-ESAbbVie Deutschland GmbH & Co. KG60
进行中（未招募）
不适用
Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Children And Adolescent Outpatients With Major Depressive DisorderEUCTR2008-001875-32-Outside-EU/EEAPfizer Inc.363